Biotech News
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
ir.minervaneurosciences.com2026-05-06 15:16 EST
BURLINGTON, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business updates and financial results for the third